Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02996721
PHASE4

A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients

Sponsor: Intermountain Health Care, Inc.

View on ClinicalTrials.gov

Summary

This study evaluates whether achieving 25-hydroxyvitamin D (25\[OH\] Vit D) levels (\>40 ng/mL) among myocardial infarction patients will result in a reduction of cardiovascular-related adverse events. Half of the patients will be randomized to receive standard of care and half will receive clinical management of 25\[OH\] Vit D levels.

Official title: A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients (The TARGET-D Study)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

634

Start Date

2017-04-03

Completion Date

2025-09-04

Last Updated

2026-11-05

Healthy Volunteers

No

Interventions

BIOLOGICAL

Vitamin D3

Vitamin D3 (cholecalciferol) will be provided to participants of the study.

Locations (1)

Intermountain Medical Center

Murray, Utah, United States